BONE AND SOFT TISSUE TUMORS
Clinical trials for BONE AND SOFT TISSUE TUMORS explained in plain language.
Never miss a new study
Get alerted when new BONE AND SOFT TISSUE TUMORS trials appear
Sign up with your email to follow new studies for BONE AND SOFT TISSUE TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young cancer patients: drug combo targets relapsed solid tumors
Disease control Recruiting nowThis study tests a combination of drugs (liposomal mitoxantrone, capecitabine, and anlotinib) in children, adolescents, and young adults whose solid tumors have returned or not responded to previous treatments. The goal is to see if this regimen can shrink tumors or stop them fro…
Matched conditions: BONE AND SOFT TISSUE TUMORS
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug shows promise for rare bone and soft tissue cancers
Disease control Recruiting nowThis study tests a new drug called QL1706 in 45 adults with advanced bone or soft tissue sarcoma that cannot be removed by surgery or has spread. Participants receive the drug every 3 weeks. The main goal is to see if the cancer stays stable for at least 12 weeks. Researchers wil…
Matched conditions: BONE AND SOFT TISSUE TUMORS
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Light-Activated nanoparticles could target sarcomas
Knowledge-focused Recruiting nowThis study is developing a new way to deliver chemotherapy directly to sarcoma tumors using tiny particles activated by light through an optic fiber. Researchers will test these nanoparticles on cells and tissue samples from 30 patients with bone or soft tissue sarcomas. The goal…
Matched conditions: BONE AND SOFT TISSUE TUMORS
Sponsor: Istituto Ortopedico Rizzoli • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC